Extracellular vesicles for drug delivery

Extracellular vesicles (EVs) are cell-derived membrane vesicles, and represent an endogenous mechanism for intercellular communication. Since the discovery that EVs are capable of functionally transferring biological information, the potential use of EVs as drug delivery vehicles has gained consider...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced drug delivery reviews Jg. 106; H. Pt A; S. 148 - 156
Hauptverfasser: Vader, Pieter, Mol, Emma A., Pasterkamp, Gerard, Schiffelers, Raymond M.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands Elsevier B.V 15.11.2016
Schlagworte:
Animals
biodistribution
Drug Carriers - metabolism
drug delivery
Drug Delivery Systems - methods
exosomes
Extracellular vesicles
Extracellular Vesicles - metabolism
Humans
isolation
microvesicles
nanomedicine
targeting
biodistribution
targeting
exosomes
Extracellular vesicles
nanomedicine
isolation
microvesicles
drug delivery
ISSN:0169-409X, 1872-8294, 1872-8294
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Extracellular vesicles (EVs) are cell-derived membrane vesicles, and represent an endogenous mechanism for intercellular communication. Since the discovery that EVs are capable of functionally transferring biological information, the potential use of EVs as drug delivery vehicles has gained considerable scientific interest. EVs may have multiple advantages over currently available drug delivery vehicles, such as their ability to overcome natural barriers, their intrinsic cell targeting properties, and stability in the circulation. However, therapeutic applications of EVs as drug delivery systems have been limited due to a lack of methods for scalable EV isolation and efficient drug loading. Furthermore, in order to achieve targeted drug delivery, their intrinsic cell targeting properties should be tuned through EV engineering. Here, we review and discuss recent progress and remaining challenges in the development of EVs as drug delivery vehicles. [Display omitted]
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0169-409X
1872-8294
1872-8294
DOI:10.1016/j.addr.2016.02.006